136 related articles for article (PubMed ID: 9123205)
1. Tolerance for graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
Transplant Proc; 1997; 29(1-2):1073-5. PubMed ID: 9123205
[No Abstract] [Full Text] [Related]
2. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
[No Abstract] [Full Text] [Related]
3. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
Greenstein SM; Sun S; Schechner RS; Tellis VA
Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
[No Abstract] [Full Text] [Related]
4. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
Sun S; Greenstein SM; Schechner RS; Tellis VA
Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
[No Abstract] [Full Text] [Related]
5. Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplantation; 1995 Jan; 59(2):309-11. PubMed ID: 7839457
[No Abstract] [Full Text] [Related]
6. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
Nakafusa Y; Arima T; Goss JA; Flye MW
Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
[No Abstract] [Full Text] [Related]
7. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
[No Abstract] [Full Text] [Related]
8. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts.
Schulak JA; Mulligan DC; Robinson A
Transplant Proc; 1997; 29(1-2):1070-1. PubMed ID: 9123203
[No Abstract] [Full Text] [Related]
9. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
[TBL] [Abstract][Full Text] [Related]
10. Tolerance induction to cardiac allografts by sequential intrathymic inoculation of disparate alloantigens.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1996 Jun; 28(3):1283-4. PubMed ID: 8658661
[No Abstract] [Full Text] [Related]
11. A second intrathymic injection of donor splenocytes improves survival of small bowel allografts.
Sun S; Greenstein SM; Kim DY; Schreiber TC; Schechner RS; Tellis VA
Transplant Proc; 1998 Sep; 30(6):2575-6. PubMed ID: 9745495
[No Abstract] [Full Text] [Related]
12. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
13. Prevention by thymectomy of tolerance induced by intrathymic injection of donor splenocytes.
Nakafusa Y; Goss JA; Flye MW
Surgery; 1993 Aug; 114(2):183-9; discussion 189-90. PubMed ID: 8342124
[TBL] [Abstract][Full Text] [Related]
14. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
[No Abstract] [Full Text] [Related]
15. Induction of tolerance to an "untolerizable" strain by double-strain intrathymic inoculation in experimental rat cardiac transplantation.
Mohiuddin MM; Yokoyama H; Reiss GR; DiSesa VJ
Transplant Proc; 1999; 31(1-2):838-9. PubMed ID: 10083364
[No Abstract] [Full Text] [Related]
16. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
Xia W; Sayegh MH; Kirkman RL
Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
[No Abstract] [Full Text] [Related]
17. Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model.
Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
Transplant Proc; 1995 Jun; 27(3):2112-4. PubMed ID: 7792902
[No Abstract] [Full Text] [Related]
18. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
19. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
Ohzato H; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
[No Abstract] [Full Text] [Related]
20. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
